Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoHealth (GOCO) Cash from Financing Activities (2020 - 2025)

GoHealth's Cash from Financing Activities history spans 6 years, with the latest figure at $31.4 million for Q3 2025.

  • For Q3 2025, Cash from Financing Activities rose 54.57% year-over-year to $31.4 million; the TTM value through Sep 2025 reached $75.1 million, up 387.25%, while the annual FY2024 figure was -$32.0 million, 51.77% down from the prior year.
  • Cash from Financing Activities for Q3 2025 was $31.4 million at GoHealth, down from $53.9 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $226.3 million in Q4 2021 and bottomed at -$156.6 million in Q4 2022.
  • The 5-year median for Cash from Financing Activities is -$1.1 million (2023), against an average of $9.1 million.
  • The largest annual shift saw Cash from Financing Activities plummeted 1036.16% in 2023 before it skyrocketed 1026.9% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $226.3 million in 2021, then crashed by 169.18% to -$156.6 million in 2022, then soared by 99.31% to -$1.1 million in 2023, then tumbled by 541.12% to -$7.0 million in 2024, then surged by 550.85% to $31.4 million in 2025.
  • Per Business Quant, the three most recent readings for GOCO's Cash from Financing Activities are $31.4 million (Q3 2025), $53.9 million (Q2 2025), and -$3.2 million (Q1 2025).